Table 3.
Correlation of calprotectin and other variables in PCOS group.
| Age | r | 0.044 |
| P | .697 | |
| BMI | r | 0.273 |
| P | .192 | |
| WC | r | 0.212 |
| P | .045 | |
| HC | r | 0.206 |
| P | .041 | |
| WHR | r | 0.072 |
| P | .570 | |
| Neutrophil | r | 0.048 |
| P | .708 | |
| Estradiol | r | 0.075 |
| P | .515 | |
| DHEA-S | r | 0.139 |
| P | .262 | |
| Glukose | r | 0.054 |
| P | .616 | |
| CRP | r | 0.422 |
| P | .151 | |
| NLR | r | 0.060 |
| P | .638 | |
| TT | r | 0.245 |
| P | .021 | |
| HOMA-IR | r | 0.295 |
| P | .005 |
Statistical significance was defined as P < .05.
BMI = body mass index, CRP = serum C-reactive protein, DHEA-S = dehydroepiandrosterone sulfate, HC = hip circumference, HOMA-IR = Homeostatic Model Assessment for Insulin Resistance, NLR = neutrophil-lymphocyte ratio, PCOS = polycystic ovary syndrome, r = correlation coefficient, TT = total testosterone, WC = waist circumference, WHR = waist-to-hip ratio.